Latest Headlines

  1. Pictor's Test Poised To Transform Hepatitis B Immunity Testing Amid CDC Guidance Shifts 12/19/2025

    With the CDC's Advisory Committee on Immunization Practices (ACIP) recommending post-vaccination antibody testing for hepatitis B, laboratories are facing new demands to assess immunity more effectively.

  2. Roche Receives FDA Approval For First Diagnostic Tests To Identify HER2-Positive Metastatic Breast Cancer Patients Eligible For ENHERTU 12/17/2025

    Roche announced today that the U.S. Food and Drug Administration (FDA) has approved additional indications for its PATHWAY anti-HER2/neu (4B5) Rabbit Monoclonal Primary Antibody and VENTANA HER2 Dual ISH DNA Probe Cocktail tests.

  3. CellTivity Scientific Receives CE Registration For The Van Gogh Microscopy System, Enabling Real Time Diagnostic Sampling Support Across Europe 12/17/2025

    CellTivity Scientific, a leader in point of care disease detection, today announced that the Van Gogh Microscopy System has received CE registration, enabling clinical use and commercial distribution across the European Union.

  4. Co-Diagnostics Performs Analysis Of Influenza Co-Primers® To Confirm Reactivity Against Flu A H3N2 Mutation 12/17/2025

    Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has performed an in silico analysis of the Co-Primers® used in its Logix Smart® ABC test* for the detection of influenza A, influenza B and COVID-19.

  5. Techcyte Awarded Patent, Strengthening Its AI Training Framework And Accelerating Development Of Digital Diagnostics 12/17/2025

    Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the issuance of a new patent covering a novel approach to training medical imaging algorithms using explicit labeling.

  6. Singlera Genomics Announces Research Collaboration With The University Of Pittsburgh To Advance Pancreatic Cancer Early Detection 12/17/2025

    Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough Genomics, a leader in the clinical analysis of genomic data and early cancer diagnostics, today announced a research collaboration with the University of Pittsburgh (Pitt) to advance the preclinical evaluation of Singlera and Breakthrough’s BT-Reveal™ Early Pancreatic Cancer Test.

  7. Aces Diagnostics Announces Key Development Partnerships For Novel LymeSeek™ Test 12/16/2025

    Aces Diagnostics Inc., a biotechnology company dedicated to delivering accurate and accessible diagnostics for Lyme disease, announced significant progress toward commercialization of its flagship LymeSeek™ test through new development partnerships with Protavio and Repado.

  8. KPM Analytics Unveils The SmartChem® 800 Series, A Next-Generation Platform For High-Throughput Wet Chemistry 12/16/2025

    Commercial laboratories face mounting pressure to process more samples with fewer staff while maintaining fast turnaround times.

  9. Researchers Develop Groundbreaking Blood Test For Lung Cancer 12/16/2025

    A UK research team has developed a pioneering blood test that could change the way lung cancer is detected and monitored.

  10. Roche Announces U.S. Launch Of Next-Generation Cobas 6800/8800 Systems And Software, Enhancing Laboratory Efficiency And Testing Capabilities 12/16/2025

    Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of the new cobas® 6800/8800 systems version 2.0 and software version 2.0.1, following U.S. Food and Drug Administration (FDA) 510(k) clearance earlier this year.